Dementia News and Research

Latest Dementia News and Research

People who are illiterate may have greater risk of developing dementia

New research has found that people who are illiterate, meaning they never learned to read or write, may have nearly three times greater risk of developing dementia than people who can read and write.

13 Nov 2019

Using AI to improve psychiatric care

A new paper in Schizophrenia Bulletin shows that artificial intelligence (AI) can help doctors to diagnose the mental health of patients with speed and accuracy. The new app designed for mobiles has been developed to improve patient monitoring using cues picked up from their speech, and is based on machine-learning tools.

13 Nov 2019

The arts could benefit health finds landmark WHO report

The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.

13 Nov 2019

Substantial changes in blood pressure over long term linked to dementia risk

In a new research study published in the open access journal PLOS Medicine, Albert Hofman and colleagues at Erasmus MC University Medical Center, Rotterdam, the Netherlands and Harvard T.H. Chan School of Public Health, Boston, United States report that people who experienced substantial changes in blood pressure over the long term were at greater risk of dementia than those who did not.

13 Nov 2019

Alzheimer's Association awarded NIH grant for psychosocial dementia care research

The Alzheimer's Association announced that it has received a $1.34 million dollar grant from the National Institutes of Health to strengthen the current framework for psychosocial research examining care for people living with dementia and their care partners.

13 Nov 2019

Art gallery programs can improve wellbeing of people with dementia, study shows

University of Canberra researchers have shown that art gallery programs can improve the wellbeing of people living with dementia – and they’ve backed it up by testing study participants’ saliva.

13 Nov 2019

The arts play an important role in improving well-being, according to a WHO report

A report has concluded that engaging in art-based activities can significantly benefit health, both mentally and physically.

12 Nov 2019

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Alzheimer's disease is the leading cause of dementia in the U.S., with approximately 5.4 million currently affected and an estimated 16 million by 2050.

11 Nov 2019

Australia has limited capacity to move future Alzheimer's therapy into wide clinical use

As in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from approval into wide clinical use, which could leave thousands of older people without access to transformative care if such a breakthrough occurs, according to a new study by RAND Australia.

11 Nov 2019

Compound that may help delay onset of Alzheimer’s can be produced in baker’s yeast

Scientists prove that ergothioneine, an important compound that may be used to delay the onset of diseases such as Alzheimer’s and dementia, can be produced in baker’s yeast.

11 Nov 2019

Artistic activities from a young age can reduce social inequalities, encourage healthy behaviors

Engaging in artistic activities such as singing and dancing from a young age can reduce social inequalities and encourage healthy behaviors, according to a new report from UCL and the World Health Organization.

11 Nov 2019

Medopad collaborates with Janssen to validate, commercialize novel automated cognitive tool

Medopad today announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and potentially commercialize the ReVeRe platform as a novel digital biomarker for Alzheimer's disease. This deal was facilitated by Johnson & Johnson Innovation Limited.

From J&J Innovative Medicine 11 Nov 2019

Regenstrief scientists will play key role in nationwide effort to improve care for dementia patients

Regenstrief research scientists Christopher Callahan, M.D., and Alexia Torke, M.D., will play a key role in a major nationwide effort to improve healthcare and quality of life for people with Alzheimer's disease and related dementias.

8 Nov 2019

New position statement lays out framework to help aging populations stay healthier

An international team of researchers have put forward a position statement, published in Science, which lays out a new healthcare framework to help aging populations stay healthier for longer.

8 Nov 2019

Top organizations announce awards for emerging leaders in brain health and dementia

To address the growing worldwide public health crisis due to dementia, the prevalence of which is expected to triple worldwide to 152 million by 2050, three leading organizations announced this year's Pilot Awards for Global Brain Health Leaders.

8 Nov 2019

Five scientists receive funds for independently designed research studies

The Center for BrainHealth, part of The University of Texas at Dallas, recently hosted the annual Friends of BrainHealth Scientist Selection Luncheon at the Dallas Country Club, where the following five scientists were awarded funds for their independently designed research studies.

7 Nov 2019

New study reveals why beta-blockers cause skin inflammation

Beta-blockers are often used to treat high blood pressure and other cardiovascular diseases. However, in some patients they can trigger or exacerbate psoriasis, an inflammatory skin disease.

7 Nov 2019

Does Parkinson's disease start in the brain or gut?

Does Parkinson's disease start in the brain or the gut? In a new contribution published in the Journal of Parkinson's Disease, scientists hypothesize that PD can be divided into two subtypes: gut-first, originating in the peripheral nervous system of the gut and spreading to the brain; and brain-first, originating in the brain, or entering the brain via the olfactory system, and spreading to the brainstem and peripheral nervous system.

7 Nov 2019

Natural language processing helps evaluate electronic messages from ESLD patients

Natural language processing, the technology that lets computers read, decipher, understand and make sense of human language, is the driving force behind internet search engines, email filters, digital assistants such as Amazon's Alexa and Apple's Siri, and language-to-language translation apps.

From Johns Hopkins Medicine 7 Nov 2019

Rapamycin prevents age-related brain vascular deterioration, study shows

A just-released study by UT Health San Antonio and collaborating institutions shows age-related decreases in blood flow to the brain and memory loss can be modified with the drug rapamycin.

6 Nov 2019

Dementia News and Research

Latest Dementia News and Research

People who are illiterate may have greater risk of developing dementia

Using AI to improve psychiatric care

The arts could benefit health finds landmark WHO report

Substantial changes in blood pressure over long term linked to dementia risk

Alzheimer's Association awarded NIH grant for psychosocial dementia care research

Art gallery programs can improve wellbeing of people with dementia, study shows

The arts play an important role in improving well-being, according to a WHO report

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Australia has limited capacity to move future Alzheimer's therapy into wide clinical use

Compound that may help delay onset of Alzheimer’s can be produced in baker’s yeast

Artistic activities from a young age can reduce social inequalities, encourage healthy behaviors

Medopad collaborates with Janssen to validate, commercialize novel automated cognitive tool

Regenstrief scientists will play key role in nationwide effort to improve care for dementia patients

New position statement lays out framework to help aging populations stay healthier

Top organizations announce awards for emerging leaders in brain health and dementia

Five scientists receive funds for independently designed research studies

New study reveals why beta-blockers cause skin inflammation

Does Parkinson's disease start in the brain or gut?

Natural language processing helps evaluate electronic messages from ESLD patients

Rapamycin prevents age-related brain vascular deterioration, study shows

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in